Our findings reveal an unexpected role for HMGCS1 as a non-canonical regulator of mitochondrial transcription and establish the HMGCS1-mitochondrial transcription axis as a promising therapeutic target to overcome cisplatin resistance in cervical cancer. The gene discussed is HMGCS1; the disease is cervical cancer.